Steinfeld, S. D., Tant, L., Burmester, G. R., Teoh, N. K., Wegener, W. A., Goldenberg, D. M., & Pradier, O. (2006). Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: An open-label phase I/II study. BioMed Central.

Steinfeld, Serge D., Laure Tant, Gerd R. Burmester, Nick KW Teoh, William A. Wegener, David M. Goldenberg, and Olivier Pradier. Epratuzumab (humanised Anti-CD22 Antibody) in Primary Sjögren's Syndrome: An Open-label Phase I/II Study. BioMed Central, 2006.

Steinfeld, Serge D., et al. Epratuzumab (humanised Anti-CD22 Antibody) in Primary Sjögren's Syndrome: An Open-label Phase I/II Study. BioMed Central, 2006.